摘要
目的探讨加味青蒿鳖甲汤治疗晚期肺癌癌性发热疗效。方法将我院收治的112例晚期肺癌癌性发热患者随机分为两组。对照组56例采用塞来昔布治疗,而试验组56例采用加味青蒿鳖甲汤治疗。比较两组患者临床疗效及白细胞的差异。结果试验组临床有效率为89.3%高于对照组73.2%,比较差异有统计学意义(P<0.05);治疗后试验组白细胞数目下降,也低于同期对照组,比较差异有统计学意义(P<0.05)。结论加味青蒿鳖甲汤治疗晚期肺癌癌性发热效果良好,具有较高的临床有效率,白细胞下降。
Objective To analyze the curative effect of modified Qinghao Biejia Decoction in the treatment of cancerous fever for patients with advanced lung cancer. Methods 112 advanced lung cancer patients with cancerous fever in our hospital were randomly divided into two groups. The control group adopted Celecoxib,the test group adopted the modified Qinghao Biejia Decoction. The clinical effect and difference of leukocyte for two groups was comapred. Results The clinical effective rate of test group（89.3%）was higher than that of control group（73.2%）（P〈0.05）. After treatment,the decreasing leukocytes for test group were lower than that of control group（P〈0.05）. Conclusion Modified Qinghao Biejia Decoction in the treatment of advanced lung cancer febrile effect is remarkable,it has higher clinical efficiency,white blood cells decreased significantly.
出处
《中国卫生标准管理》
2016年第2期131-132,共2页
China Health Standard Management
关键词
加味青蒿鳖甲汤
晚期肺癌
癌性发热
Modified Qinghao Biejia Decoction
Advanced lung cancer
Cancerous fever
